The global antiparasitic drugs market size was valued at USD 17.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.06% from 2024 to 2030. Parasitic infections, such as malaria, helminthiasis, and others, affect millions of people worldwide, particularl... Read More »
January 2024The global corticosteroids market size was valued at USD 5.30 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.49% from 2024 to 2030. This is attributed to the rising geriatric population, increasing incidence of cancer, increasing healthcare expenditu... Read More »
January 2024Cephalosporin Drugs Market Size & TrendsThe global cephalosporin drugs market size was valued at USD 19.38 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.94% from 2023 to 2030. The high incidence of infectious diseases is prompting health authori... Read More »
January 2024The global ear infection treatment market size was valued at USD 11.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.33% from 2024 to 2030. Advancements in continuous renal replacement therapy (CRRT) availability, especially in corporate and private... Read More »
January 2024The global carboprost tromethamine market size is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2030. The growing prevalence of postpartum uterine hemorrhage and abortion has created immense opportunities for key market players. In addition, other factors ... Read More »
January 2024The global cytomegalovirus (CMV) treatment market was valued at USD 436.7 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% over the forecast period. The CMV treatment market is driven by the increasing prevalence of CMV infection, rising awareness ... Read More »
January 2024The global cytotoxic drugs market size was valued at USD 14.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2030. The growing global burden of cancer, the aging population, and advancements in cancer therapies are some of the notable... Read More »
January 2024The global sirolimus market size is expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030. Sirolimus is a mTOR inhibitor drug used for immunosuppression in patients. The increasing number of organ transplantations is the major reason behind the growth of the sirolim... Read More »
January 2024The global aminophylline market size is expected to grow at a compound annual growth rate (CAGR) of 2.3% from 2024 to 2030. This growth can be attributed to the rising prevalence of respiratory disorders, a surging demand for cost-effective treatment options, and an increasing number of ... Read More »
January 2024The global barbiturate drugs market size was valued at USD 483 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.12% from 2024 to 2030. Barbiturate drugs are a class of drugs that primarily act on the central nervous system. They were historically used ... Read More »
January 2024The global medical foods market size was valued at USD 23.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.1% 2024 to 2030. The market growth is driven by the rising prevalence of chronic diseases like Alzheimer's, ADHD, osteoporosis, osteoarthritis... Read More »
January 2024The global alopecia market was estimated at USD 8.77 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as people a... Read More »
January 2024The global lidocaine hydrochloride market size is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. The growing number of surgical procedures and an increase in the number of dental, cosmetic, and plastic surgeries conducted globally are contributing to ... Read More »
January 2024The global alexipharmic drugs market was valued at USD 3.4 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.12% from 2023 to 2030. The primary factor contributing to the market's expansion is the global increase in mortality rates resulting from drug ... Read More »
January 2024The global anal fistula treatment market was valued at USD 756.23 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.1% over the forecast period. The market growth is attributed to the increasing geriatric population, rising incidences of constipation, a... Read More »
January 2024The global carglumic acid market was valued at USD 137.2 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.43% from 2024 to 2030. The growth of the carglumic acid market is attributed to several factors, including the increased prevalence of several can... Read More »
January 2024The global herpes simplex virus treatment market size was estimated at USD 2.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. The market growth can be attributed to the growing concerns over herpes simplex virus (HSV) infection... Read More »
January 2024The global benzodiazepine drugs market is expected to grow at a compound annual growth rate (CAGR) of 2.68% from 2024 to 2030. Major factors responsible for the market growth include the rising incidence of stress disorders and anxiety, the development of new effective medications for se... Read More »
January 2024The global opioid induced constipation market is anticipated to experience a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030. The primary driver of this growth is the increasing number of geriatric patients who are prescribed opioid analgesics, such as morphine, hydromorphon... Read More »
January 2024The global tacrolimus market size is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. The worldwide increase in the number of transplants and a surge in immunosuppressive research and development is anticipated to fuel the growth of the market. For inst... Read More »
January 2024